Zimmer looking at Sintx for spine and total joints?

[anonymous]

I was scammed by sintx and Scott Mosier. Lost good money on their lies, in fact, I know a few people now who have been scammed by what Scott Mosier says about Zimmer and sintx. It’s very obvious now that it was all BS, and hope for a major lawsuit against sintx and their stock pumping lying dogs. ZB’s Cafepharma has been posted to investorhub, let’s see what happens now as 100’s of investors have access to the lies spewed for years that I just found out about as well. Horrible look for sintx this crap going viral, a 2 cent stock now doing offers at 2 cents to raise money are crooks. Throw them in jail. Fraud is real here.

 

[anonymous]

Sintx stock pumper Scott being dragged through the mud on Sintx forums currently, being exposed for years and years of stock pumping. Truly great to see, even though he’s doubling down on Zimmer buying out sintx, most can see the the fraud at this point for themselves. Sintx now under 10 cents rule violation, as well as being under 1.00 now for 6 months next week and will receive a delisting notice from nasdaq, requiring sintx to do another reverse split and further destroy shareholders, rinse and repeat the same thing for years and years, while burning cash at an unsustainable rate. Bankruptcy looming soon here, as all they can sell are more shares through dilution for money. their days of free paychecks from investors are soon over, hopefully via a fat lawsuit rather then letting them destroy themselves.

 

[anonymous]

The shitshow continues. Zimmer continues to get dragged through the mud with this POS company sintx using your name to dilute investors to sell shares. Over 100 million new shares in last few months, truly pathetic penny stock fraud behavior, all prior to the upcoming 300-1 reverse split to decimate shareholders even more. Scott Mosier the narcissist will lie for sintx until the SEC locks him up with Sintx CEO and the rest of the fraudsters.
https://investorshub.advfn.com/SiNtx-Technologies-SINT-27931

 

[anonymous]

Sintx fraudsters at it again! Sonny Bal is the worst of the worst. The guy will take the clothes off your babies back and not think twice about it. SEC should lock them all up, scammed over quarter of a billion dollars from investors and still don’t care and doing it again right now. Hopefully Nasdaq calls the BS this time and kicks them to the curb. Utah is becoming the state of fraud for bio med. insane.

 

[anonymous]

The shit show at Sintx continues with the lies. Now the Zimmer spin off was all for Sintx…. Fing insanity at Sintx with their lying dogs claiming Zimmer is buying them when they have added 150 million shares the last few weeks to raise a few million dollars and then Reverse Split of 300 to 1 coming to take those share back from investors and then right back down to penny stock land. Zimmers name being used non stop, it’s gross. Zimmer and Sonny Bal together at last? Lol, no F’ing way. I don’t know anyone who respects Sonny Bal, ex surgeon, now business con man.

 

[anonymous]

The shit show at Sintx continues with the lies. Now the Zimmer spin off was all for Sintx…. Fing insanity at Sintx with their lying dogs claiming Zimmer is buying them when they have added 150 million shares the last few weeks to raise a few million dollars and then Reverse Split of 300 to 1 coming to take those share back from investors and then right back down to penny stock land. Zimmers name being used non stop, it’s gross. Zimmer and Sonny Bal together at last? Lol, no F’ing way. I don’t know anyone who respects Sonny Bal, ex surgeon, now business con man.

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174314579

 

[anonymous]

Sintx 2016 10k

Together with a strategic partner, we have initiated biomechanical testing of our solid silicon nitride femoral heads. The results of this test will be released in 2017​

This quote indicates the results of testing of their femoral head with a strategic partner will be released in 2017.
Those results were released testing Sintx Femoral head against Biomet's E1 liners. Thus Zimmer Biomet, or any of its subsidiaries, is Sintx strategic partner in this testing as it participated in this study by supplying its IP.

Amedica and Zimmer-Biomet (Tokyo Office) provided the femoral heads and acetabular liners; however, neither company actively sponsored the research​

2016 10-k pg 13: https://www.sec.gov/Archives/edgar/data/1269026/000149315217010752/form10-k.htm
2017 results: https://ir.sintx.com/news-events/pr...nces-results-of-independent-femoral-head-wear

SiNtx Technologies Inc (SINT): 24/7 trying to force a bs prediction on...

 

[anonymous]

Sintx never released the 2nd study results as they said they would…. Wonder why…. Like the life long joint program maybe they discovered that femoral heads were a no go… On the bright side CEO Sonny Bal gonna quit soon, this final 300 to 1 reverse split gonna be the last that Nasdaq and SEC let happen? Everyone tired of this scam. The pumpers can’t even get stock price above 4 cents….. what a scam joke of a company. BOD all need to go to jail.

 

[anonymous]

These scientific studies would say otherwise in regards to Si3n4 being used in a hip implant.

Silicon Nitride, a Close to Ideal Ceramic Material for Medical Application

examples of their medical applications that relate to spinal, orthopedic and dental implants, bone grafts and scaffolds, platforms for intelligent synthetic neural circuits, antibacterial and antiviral particles and coatings, optical biosensors, and nano-photonic waveguides for sophisticated medical diagnostic devices are all covered in the research reviewed herein. The examples provided convincingly show that silicon nitride is destined to become a leader to replace titanium and other entrenched biomaterials in many fields of medicine.

Silicon Nitride, a Close to Ideal Ceramic Material for Medical Application

========================================

Silicon Nitride = Next Gen Hip Implant Material

Silicon nitride, silicon carbide and diamond-like carbon as non-oxide ceramics are considered to be the new generation of materials used in hip prosthetics, particularly in the manufacture of acetabular cups, due to their excellent biocompatibility, osteointegration, and tribological and mechanical properties, but all three materials need more study. However, silicon nitride is the nearest to commercialization, through businesses such as Amedica Corp. and SyntX Technologies

Im guessing the authors meant Sintx Technologies. Amedica being the companies former name before the name was sold to CTL.
Updates on Biomaterials Used in Total Hip Arthroplasty (THA)

 

[anonymous]

Scott Mosier. Sintx gave your name up to us awhile ago, we know you are nothing more then BS. Keep avoiding the fact sintx wont talk about the follow up hip study they said was coming. Ask sintx, ask Sonny Bal about that hip study. There’s a reason why sintx went to the lifelong joint program at the end of that study, they failed in their endeavor. Quit posting your BS Scott Mosier, you are the definition of a failure, your nothing more then a narcissist con artist. That’s the only Fact about you. Keep living up to it.

 

[anonymous]

Ok, lots to unpack. First off, youre claimng that someone at Sintx, or maybe formally at Sintx (?), gave my name to whomever "Us" is. So youve just confirmed that you represent, or are a part of, a group of people.
That group has claimed that I work for Sintx pumping the company to help it sell shares. That represents opposing concepts. If I worked for Sintx as has been claimed many times, they would not reveal who i am as that would implicate them in fraudulent activities. Given how unlikely that is, I obviously do not work for Sintx in any way shape of form.
Now if Sintx were to expose my name with malicious intent, that implies that they do not want me to post about all the connections between Sintx and Zimmer Biomet. Meaning personnel in management want to hide these ties. Why would personnel at Sintx want to hide the ties between Sintx and Zimmer Biomet yet be so blatant about the ties by mentioning Zimmer Biomet contributions in testing their products together in a press release? Again these are opposing concepts. Thus its unlikely that anyone currently employed would do such a thing. So if anyone gave my name out it was likely Mike Houston former VP of IR at Sintx. That is if you are telling the truth. Since this has been claimed before years ago, its seems plausible. I do hope Mr. Houston was not let go from his IR position because i said something in an open forum that he told me that i shouldnt have. I had no malicious intend against him thats for sure. I was simply sharing information with the public as i continue to do.

I was not avoiding that Sintx has not revealed the longer study about its femoral head as you claim. My reference of those two scientific studies was meant as a counter point to your implication that Sintx femoral head was not viable for use in hip implants. Those studies state otherwise, including coatings. One study was published in 2021 3 years after the end of the LifeLongJoints program and the other one was published end of 2023.
In regards to the LifeLongJoints program, you're claiming the program pertained to the use of Si3N4 femoral heads. That is untrue. From the literature ive read, the LLJ program was not after utilizing Si3n4 femoral heads but geared toward the application of Si3N4 coatings to prolong the life of metal components within implants.
Whatever reason Sintx joined the LLJ program for a time, it does not use the same method of applying Si3N4 to metal components. In fact alot of Sintx research now is geared toward 3D printing Si3N4 on metal.
On Zimmer Biomet side, they hired Dr Saurabh Lal from the LifeLongJoints program December 2018 for their anti-pathogenic coatings program in Swindon, UK. Dr. Lal has published several papers on Si3n4 coatings making him an interesting and complimentary addition to Zimmer Biomet.

A couple more things before i end this reply. First, according to Sintx most recent presentation, there is renewed interest in its Femoral Head and Si3N4 for acetabular shell. Im sure i do not need to remind you that Sintx previously coated Biomets G7 Acetabular shell, which Zimmer Biomet did not supply as the strategic partnership only applied to femoral heads, with Sintx Si3N4 and published that study in 2019. As Zimmer Biomet was its strategic partner in regards to femoral head and testing was completed on Biomet's G7 shell, then if theres renewed interest itd most likely be from Zimmer Biomet/subsidaries.

Lastly you continue to employ ad hominem attacks on the messenger(poster) instead of addressing the content of the post. This is a method of disinformation to distract from the truth. Also your posts seemed geared to goad/antagonize/make me emotional. Again a method of disinformation. If Sintx was so terrible, you could just stick to the facts in your posts. Thus since you have resort to methods of disinformation in your posts, it must not be as bad as your posts claim.

Evidence backing my claims:

LifeLongJoints: Aims and Objectives

In response to these challenges LifeLongJoints was designed to deliver next-generation, functional Silicon Nitride coatings for articulating surfaces and interfaces of total hip replacements (THR) that produce longer lasting implants.

Silicon Nitride Coatings for Improved Implant Function | LifeLongJoints | Project | News & Multimedia | FP7 | CORDIS | European Commission

ARTHROPLASTY (Silicon Nitride)
Renewed interest in silicon nitride’s use as a femoral head and acetabular cup.

https://d1io3yog0oux5.cloudfront.ne...INTX+Corporate+Overview+-+Jan+'24+-+Rev+J.pdf

Saurabh Lal
Zimmer Biomet · Research
BTech, PhD
https://www.researchgate.net/profile/Saurabh-Lal

 

[anonymous]

100% Fact that it was Sintx that gave up your name. It was Amedica at the time, even then some at Amedica were sick of your BS. You were exposed as a fraud, and have only been proving yourself to be a fraud for years to follow. Congrats Scott, how’s it feel to be part of ripping people off over 100 million dollars? What is it close to 300 million now they have blown through? What were revenues last 5 years combined? It’s all a dream, no reason for someone to be defending Sintx, especially after they Doxxed you to us for the fraud you are. Think about first time you saw your info online and what time period it was, and how it wasn’t your usual suspects. Then think about who you have ever communicated with at Amedica at the time. One of those people did not like your BS, and if you looked hard enough you would see who that was and where they posted your info. Everyone knows you are a fraud, and always have been, blaming everyone and everything except yourself.

 

[anonymous]

What the following will show is that there has been a conspiracy of funds, shorting and distorting SINT/AMDA & Sintx/Amedica. My next post will give some insight into how this family of funds might operate.

Plaintiff further asserts that many of the potential investors that it contacted on behalf of Defendant operate as a family of hedge funds, all managed by the same investment advisor.

List of potential investors the Plaintiff was referencing. All the funds that seem to be connected are in red.

List named the following:
Anson Funds Management LP and its affiliates
Ayrton Capital, Altos Opportunity Fund and their
affiliates
Crede Capital Group, Acquitas Capital and its affiliates
CVI Investment, Heights Management, SIG and their
affiliates
Connective Capital and its affiliates
Empery Asset Management and its affiliates
Intracoastal Capital LP and its affiliates
Hudson Bay Capital Management and its affiliates
Ionic Venture LLC and its affiliates
Lind Partners and its affiliates
Li Capital Global Opportunities Master Fund and their
affiliates
Sabby Management LLC and its affiliates

https://images.law.com/contrib/cont.../51-2023-08-31-043-Order-Denying-SJMotion.pdf

List of Funds that have had stakes in AMDA/SINT at one time or another. You'll notice that 3 of the family of funds bought recent offerings of Sintx.

4/01/2024 L1 Capital Global Opportunities Master Fund, Ltd.
EDGAR Filing Documents for 0001079973-24-000472

2024-05-14 13F Anson Funds Management LP 959,297 47
https://fintel.io/so/us/sint

2/07/24 Lind Global Fund II LP
EDGAR Filing Documents for 0000929638-24-000396

2/16/2023 INTRACOASTAL CAPITAL, LLC
EDGAR Filing Documents for 0001213900-23-012455

2/14/2023 Lind Global Fund II LP
EDGAR Filing Documents for 0000929638-23-000614

05/18/2018 CVI Investments, Inc.
EDGAR Filing Documents for 0001104659-18-034362

01/19/2017 SABBY MANAGEMENT, LLC
EDGAR Filing Documents for 0001535610-17-000068

07/14/2016 ALPHA CAPITAL ANSTALT
EDGAR Filing Documents for 0001213900-16-014963

9/14/2015 Frigate Ventures LP = Anson Group

This Schedule 13G (this “Schedule 13G”) is being filed on behalf of Frigate Ventures LP (d/b/a Anson Group), a Texas limited partnership (“Frigate”), Admiralty Advisors LLC, a Texas limited liability company (“Admiralty”), Mr. Bruce R. Winson, the principal of Frigate and Admiralty, M5V Advisors Inc. (d/b/a Anson Group Canada), an Ontario, Canada corporation (“M5V”), Mr. Adam Spears, a director of M5V, and Mr. Moez Kassam, a director of M5V, relating to Common Stock, $.01 par value (the “Common Stock”), of Amedica Corporation, a Delaware corporation (the “Issuer”).

EDGAR Filing Documents for 0001193125-15-319457

Hudson Bay Capital Management LP 2,789,867 2.16 870,438 Sep 30, 2015
SiNtx Technologies Inc (SINT): AMDA Institutional Holders(as of 9/30/15...


XenaLives connecting CVI to ALPHA CAPITAL ANSTALT
SiNtx Technologies Inc (SINT): There will be footprints - ALPHA CAPITA...


https://www.reddit.com/r/wallstreet...how_to_run_a_pyramid_scheme_but_on_the_stock/

https://casetext.com/case/augenbaum-v-anson-invs-master-fund-8

https://images.law.com/contrib/cont.../51-2023-08-31-043-Order-Denying-SJMotion.pdf

 

[anonymous]

This is essentially how the Anson family of funds (is Anson at the top of this family?) work SINT and its offerings.

Here is a trade that is almost guaranteed to make money, though it is also double super illegal.

These companies -- there were 13 of them, all pretty small -- raised money through what the SEC calls "confidentially marketed public offerings." A company would engage an investment bank, which would call up potential investors and ask if they wanted to buy shares in the company. The bank would do this before the company publicly announced the offering, and would "wall-cross" the potential investors, making them agree to keep the information about the offering secret until it was announced publicly.

So here's a predictable stock-market pattern and an easy way to exploit it: If a company calls you up to ask you to invest in its upcoming public offering, you should (1) say yes, (2) sell the company's stock short before the public announcement, and then (3) buy the stock back in the public offering, generally at a 10+ percent discount, a few days later.

This is of course not legal advice! It is a great trade, but it is also double super illegal, insofar as:

There is a specific SEC rule against short selling stock just before a public offering and then buying back the stock in the offering, 5 and
There is a general, and much more important, rule against trading on purloined material nonpublic information, and this is that.

trading in breach of that agreement, you are clearly violating not just the contract, but also insider trading laws, which make it illegal to trade "in breach of a fiduciary duty or other relationship of trust and confidence, while in possession of material, nonpublic information about the security."

But, you know, who will check?

Some of the funds would get wall-crossed, and then they'd tip each other and trade in the other funds to try to obscure what was going on:

When they were successful in obtaining such information, Fishoff shorted the issuer’s stock in advance of the offerings, directed trading by Chernin and Costantin in those instances when he did not place the trades on his own, and tipped Petrello, who then also shorted the stock through Brielle and Oceanview.

In many instances, the Fishoff-controlled entities for which Chernin and Costantin were fronting also participated in the offering, with the stock going to Featherwood’s account and often being used to cover the short sales.

This right here is most likely how this family of funds worked. 1+ of them would get information of a forthcoming offering which it would later participate in, and tip the others off so they can pre-short. Not sure why the author says pre-short, wouldnt this be naked shorting? They then used the shares from the offering that Fund #1 received to cover those naked short positions?

By cheating on their wall-cross agreements and shorting the stock, these guys had the effect of driving down the stock price, which probably reduced the price in the offering. These companies probably got less money for their stock because their nonpublic information was (allegedly) used against them.

Though you could have a more cynical view of this sort of thing. A company needs to sell stock, but worries that announcing a public offering will drive down its stock price and not produce any takers. So it calls some investors up privately and tells them it's doing a deal. Those investors agree to invest in the deal, but before the deal is announced they lay off their risk by shorting the company's stock. Then the deal is announced and the investors buy shares from the company to (illegally) cover their shorts. The investors get their 10 percent, or whatever, discount to the market price as a commission; their real function is not to invest in the deal but to intermediate between the company (which can't sell stock without a publicly disclosed offering) and the unsuspecting public (which buys from the "investors" before the public disclosure). The wall-cross agreement creates deniability for the company. No one's stealing from the company; they're helping the company get a deal done that would otherwise be much harder to achieve. The victims are the public who buy from the insider traders at the inflated, pre-announcement price.

There is definitely evidence supporting this, especially between 2022 RS & 2024 RS. For instance, Lind Group participated in the offering, these funds naked shorted from as high as .50s before Lind used their shares to cover those shorts at .15. Thus this group of funds "laid off their risk", making millions in a few days, and did in fact work as an intermediary between the company and the public as they dumped shares. Lind Group sold off its shares in a matter of days. This group of investors gets a hell of alot more than 10% off these offerings. After factoring in the 200:1 split theyve been shorting since 100 with a hell of a pump and dump between .04 to .22 pre-split (8-44 post split).

https://web.archive.org/web/2019033...aders-made-some-easy-money-on-stock-offerings

Something posted on Ihub by XenaLives years ago and it seems to correlate with all this, especially post split as theyve been walking the price down.

The 10000 can be wash traded back and forth freely between colluding computers. Tons of money is made so they can now walk the stock down even lower because risk has been reduced.

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=139777542

 

[anonymous]

According to this lawsuit, Ansons and its related funds go after companies with valuable assets... This explains why SINT is so undervalued as its been after Sintx IP for going on a decade. IP thats destined to take over the ortho industry according to one study linked below. Because of that destiny and Zimmer Biomets long interest in Sintx, is why Zimmer BIomet and those working for it should care. Ansons family of hedge funds is trying to steal the tech from underneath it. Tech Zimmer Biomet planned to use to increase its revenue through licensing.

Their playbook is simple: they find a promising company like Nano that has attracted significant investment, furtively acquire a large position, and then seek to dismantle the company and distribute its cash for Defendants’ own benefit.

EX-99.3


So Lets examine the value of Sintx and its IP here from a few angles. This should show exactly why Anson's family of funds would be trying to take over Sintx through hostile means. It represents alot of potential money for them if they can succeed. A work in progress.

Transitive Property:

In 2003, Zimmer acquired a materials company for $232m with $108m of it upfront and the remaining $124m coming over the next two years based on sales milestones. Before announcing its partnership with Zimmer, Implex had revenue about the same as Sintx should achieve this year. Its material Hydrocel, Trabecular Metal, could be used for multiple orthopedic implants. Spine, dental, hip, shoulder, and i think knee. That said, Trabecular metal cannot be used as a coating or imbued in materials like silicon nitride can to bring those materials its beneficial enhancements. Thus its market potential in the ortho/dental markets was smaller.

Thus Sintx valuation should be at minimum based on what similar companies are worth: $232m

Accumulated Deficit and Tax Write-off

Sintx Accumulated Deficit = $271.6m. For an acquiring company to utilize this for tax write off purposes Sintx IP would have to be valuable enough to bring in sufficient revenue. However as the cost to acquire Sintx would cost millions between accounting audits, lawyers, golden parachutes, etc.. Sintx accumulated Deficit would likely represent about the same value as what Implex was acquired for to an acquiring company. That is only if Sintx IP couldnt generate more revenue than Sintx deficit. The following will show that it can easily.
Also, acquiring Sintx for that amount would increase goodwill which is an asset the acquiring company can depreciate and thus provide additional tax benefit as well as increase its assets.

Potential Market Size

One particular thing about Sintx is its current sales represents a fraction of 1% of its potential revenue because it has not actually transitioned into the commercialization phase yet. The 99% of its products remain in R&D stage. Sort of like a pharma company.

Silicon Nitride increases osteointrgration, improves imaging, and is antimicrobial (antiviral, antibacterial, antifungal) while being bioactive and biodegradable. That means as it corrodes the material breaks down into materials the body can use. For instance in an aqueous solution, Si3N4 turns into orthosilicic acid which the body utilizes for bone growth. Unlike other materials used in orthopeadic implants, Si3N4 shouldnt accumulate in the body as it can be excreted. Meanwhile Titanium, Trabecular Metal, PEEK, ZTA, all accumulate in the tissue, blood and/or organs. Metals seem to spread through the body while other ceramics and plastics mostly accumulate locally. This is all important to understand when you consider that Si3n4 is destined to replace current materials used in the $64 billion ortho implant industry. As Si3n4 can be used as a coating for metal implants and can be imbued in PEEK materials, it could and should capture almost the entire ortho industry but only though partnerships and licensing.

Markets Si3n4 can be used in (not comprehensive)

Otho Market = $64 billion
Personal Protective Equipment market = $79.53 billion
Global Catheter market = $55bn
Antibacterial market = $44.5bn
Wound Care market = $22.25bn
Biosensors Market = $28.9bn
Condom Market = $11.6bn
Dental Implant market = $4.99bn
Armor Materials Market = $13.59bn

Total = $324.36bn

Its honestly overwhelming the size of the markets Sintx material can be used in. Hypothetical scenario using 5% market penetration with a 5% licensing fee equates to $811m in yearly licensing revenue. Thus Si3N4 is worth at least $800m in potential yearly revenue for an acquiring company through licensing revenue according to this scenario. Its ability to penetrate the above markets will vary but Ortho & Catheter markets are markets that Si3N4 should significantly penetrate; with Wound Care & Dental being up there as well. Condom market is more hypothetical based on Si3N4 ability to kill Herpes and possibly other STI. However would need to be studied further to ensure it doesnt impact the delicate microbe balance inside a vaginal canal.


A basic roadmap laid out of Zimmer's intentions for Sintx back in 2011. This quote predates Sintx vast IP portfolio expansion. Any markets Zimmer Biomet does not currently participate in, that Sintx does, represents potential markets Zimmer Biomet can utilize Sintx to bolster its revenue through licensing as well as diversify those revenue sources.

AnonymousMay 24, 2011 at 3:42 PM
Zimmer is looking at purchasing Amedica flat out for their techology to bolster sales in spine through licensing and to purchase the next generation of hip and knee implants. You heard it here on TSB.

Sources:
https://web.archive.org/web/2024040...ogger.blogspot.com/2011/05/whos-next.html?m=1
https://orthospinenews.com/2021/01/...y-2025-as-acquisitions-surge-says-globaldata/
https://www.grandviewresearch.com/industry-analysis/personal-protective-equipment-ppe-market
https://www.grandviewresearch.com/industry-analysis/catheters-market-analysis
https://www.grandviewresearch.com/industry-analysis/wound-care-market
https://www.grandviewresearch.com/industry-analysis/biosensors-market
https://www.grandviewresearch.com/industry-analysis/condom-market
https://www.mordorintelligence.com/industry-reports/armor-materials-market
https://www.grandviewresearch.com/industry-analysis/dental-implants-market

 

[anonymous]

4/01/2024 L1 Capital Global Opportunities Master Fund, Ltd.
EDGAR Filing Documents for 0001079973-24-000472

Notice that on April 1st, L1 filed its 13G indicating it had 8.8% of outstanding stock. Two days later, Sintx announces an offering at 2.1 cents adding 71m shares of stock.

(2) Based on 51,080,139 shares of Common Stock outstanding as reported in the Issuer’s filings with the Securities and Exchange Commission.

Once this offering completed, L1 stake in Sintx became 3.6%.

This indicates that Sonny is not simply raising funds, but that hes preventing these funds from accumulating too large of a position. Thus this game of massive dilution and reverse splits seems to be a game of Sonny defending Sintx from this group of hostile funds. As long as this group of funds continue to attempt to take over Sintx through hostile means, we can expect this to continue. However with Nasdaq putting Sintx on probation for a year, it's limited on its ability to raise funds while diluting this groups position as it must stay over $1. Sintx needs to do a private placement offering which is likely why Sonny has indicated that Sintx is exploring Strategic Opportunities. Sell Sintx Armor to NP Aerospace is one option as NP Aerospace needs a US facility and Utah is a good location for manufacturing and military connections. It could also try to get one of its partners to take a stake. As Ansons group of funds come at you sideways, they'll try to disrupt any such negotiations. Sintx is in a precarious predicament right now. Can Zimmer Biomet not step up already?

SINTX Technologies to Explore Strategic Opportunities


Board of Directors has initiated a process to explore potential strategic options for the Company.

https://ir.sintx.com/news-events/pr...chnologies-to-explore-strategic-opportunities

April 3rd Press Release
https://ir.sintx.com/news-events/pr...ogies-announces-pricing-of-1-3-million-public

========================================

Evidence of these funds attacks on Sintx are extensive in this and one other thread called Sintx. You can read about some of their techniques at the following website:

Lies of Rhetoric #4: 18 Rules of Disinformation

Market Manipulation: Exposing the Tactics of Stock Bashers - FasterCapital

1. Consistent Negativity:
2. Lack of Supporting Evidence:
3. Frequent Use of Emotional Appeals:
5. Lack of Transparency:
Market Hype: Unmasking Stock Bashers: Attempts to Manipulate Buzz - FasterCapital

Not mentioned here is their attempts to intimidate me because i am the main person defending against them on social media and now exposing them. Again you can see evidence of this here and within Sintx thread.

 

[anonymous]

Notice that on April 1st, L1 filed its 13G indicating it had 8.8% of outstanding stock. Two days later, Sintx announces an offering at 2.1 cents adding 71m shares of stock.



Once this offering completed, L1 stake in Sintx became 3.6%.

This indicates that Sonny is not simply raising funds, but that hes preventing these funds from accumulating too large of a position. Thus this game of massive dilution and reverse splits seems to be a game of Sonny defending Sintx from this group of hostile funds. As long as this group of funds continue to attempt to take over Sintx through hostile means, we can expect this to continue. However with Nasdaq putting Sintx on probation for a year, it's limited on its ability to raise funds while diluting this groups position as it must stay over $1. Sintx needs to do a private placement offering which is likely why Sonny has indicated that Sintx is exploring Strategic Opportunities. Sell Sintx Armor to NP Aerospace is one option as NP Aerospace needs a US facility and Utah is a good location for manufacturing and military connections. It could also try to get one of its partners to take a stake. As Ansons group of funds come at you sideways, they'll try to disrupt any such negotiations. Sintx is in a precarious predicament right now. Can Zimmer Biomet not step up already?

SINTX Technologies to Explore Strategic Opportunities


Board of Directors has initiated a process to explore potential strategic options for the Company.

https://ir.sintx.com/news-events/pr...chnologies-to-explore-strategic-opportunities

April 3rd Press Release
https://ir.sintx.com/news-events/pr...ogies-announces-pricing-of-1-3-million-public

========================================

Evidence of these funds attacks on Sintx are extensive in this and one other thread called Sintx. You can read about some of their techniques at the following website:

Lies of Rhetoric #4: 18 Rules of Disinformation

Market Manipulation: Exposing the Tactics of Stock Bashers - FasterCapital

1. Consistent Negativity:
2. Lack of Supporting Evidence:
3. Frequent Use of Emotional Appeals:
5. Lack of Transparency:
Market Hype: Unmasking Stock Bashers: Attempts to Manipulate Buzz - FasterCapital

Not mentioned here is their attempts to intimidate me because i am the main person defending against them on social media and now exposing them. Again you can see evidence of this here and within Sintx thread.

Scott Mosier, the sintx fraud. Finally sees what the world sees. Sonny Bal has let everything happen to sintx on his watch, with his knowledge of what’s going to take place. Finally Scott admits Sonny Bal has not done anything to protect Sintx Investors from these crooks, who again on Sonny Bals watch, have toyed with Sintx with an immense amount of knowledge why Sonny Bal had ZERO idea how to run a public traded company. This is all on Sonny Bal and the BOD for being in bed with these companies. We know Sonny talks to Maxim, of course he’s gonna talk to Anson, ascendiant ect. All players who know how to play the game, and they sure as hell knew how to drag Sonny Bal dumbass along the entire time. Sonny Bal ruined Sintx, that’s no conspiracy. Wake up Scott, moron.

 

[anonymous]

OK so you dont deny how large the markets are Sintx can play in, nor how valuable Sintx IP is. You also dont deny thats Sintx has been under attack by hedge funds for the last nine years and that the stock is only so undervalued because of this. No you dont deny any of that, you're just shifting the blame to management for not doing enough to protect shareholders from such entities attacks. Let me ask you, what do small companies with limited resources do to stop a conspiracy of hedge funds from manipulating its stock when those hedge funds engage in illegal methods? According to one lawsuit against Ansons family of funds, they were accused of hiring people to take out loans and then not pay them back. Meaning they attack business relationships and customer relationships hurting a companies revenue stream. This in addition to manipulating the stock price and trying all means to scare investors away.

BTW shareholder rights offerings are the best tool management has employed to protect its longterm shareholders with its full ratchet anti-diltive measures. Meaning the exercise price lowers which each of these offerings that Sonny has to use to prevent these funds from attempting a hostile takeover. If this group does try this, well, CTL can just acquire Sintx core IP in a crown jewels defense. The only hope this group has is to force bankruptcy but Sintx has no real debt. Maybe their goal is simply to delay commercialization?

 

[anonymous]

All Nonsense because Sonny Bal in bed with the death spiral financiers. It’s his only play. Literally. Or the light would be off and they would all be jobless, you know that Scott. Quit playing stupid. Sonny has no idea how to run a public traded company, the wolves smelled that sheep from 1000 miles away, and took advantage of someone who was literally clueless, and frantic to keep the lights on. A real ceo would have seen this coming a mile away, countless investors saw this while you dismissed everyone of them deleting conversations between Sonny bal and them. Insane. Scott Mosier, still ruining lives.

 

[anonymous]

Meaning they attack business relationships and customer relationships hurting a companies revenue stream.

Catalyst Capital files $450-million lawsuit accusing Anson Funds, West Face of short-selling 'conspiracy'​

Lawsuit claims ‘Wolfpack Conspirators’ worked with group of borrowers who had defaulted on loans to Callidus

Catalyst Capital Group Inc. has launched a lawsuit against Anson Group Canada, a privately held asset manager with operations in Canada and Texas, and Toronto-based private equity firm West Face Capital Inc., accusing them of participating in a “manipulative ‘short and distort’ campaign.”

The alleged target was publicly traded Catalyst subsidiary Callidus Capital Corp., claims the lawsuit, which dubs the Anson, West Face and several associated and unrelated individuals as “Wolfpack Conspirators.”

Article content
The lawsuit, filed Tuesday in Ontario’s Superior Court of Justice, claims the group targeted Callidus with a short-selling strategy that involved coordinating with and providing financial support to a group of borrowers who had defaulted on loans to Callidus, and were fighting to prevent Callidus from collecting.

It also alleges use and attempted use of the news media to further their short-selling campaign, improper use of a new regulatory whistle-blowing program, and coordinated buying and selling of shares.

Catalyst Capital files $450-million lawsuit accusing Anson Funds, West Face of short-selling 'conspiracy'